Download - Aetiology - iacld.ir
![Page 1: Aetiology - iacld.ir](https://reader033.vdocuments.site/reader033/viewer/2022051000/6276753fe53b5e45d469ae0b/html5/thumbnails/1.jpg)
![Page 2: Aetiology - iacld.ir](https://reader033.vdocuments.site/reader033/viewer/2022051000/6276753fe53b5e45d469ae0b/html5/thumbnails/2.jpg)
Aetiology
Human or animal infection with larval stage
(Metacestod=Cyst) of Echinococcus:
E. granulosus Cystic echinococcosis, hydatidosis,
hydatid disease
E. multilocularis Alveolar echinococcosis,
alveolar hydatid disease
E.vogeli
E. oligarthrus Polycystic echinococcosis
![Page 3: Aetiology - iacld.ir](https://reader033.vdocuments.site/reader033/viewer/2022051000/6276753fe53b5e45d469ae0b/html5/thumbnails/3.jpg)
(Hydatid cyst)
•Endocyst:
laminated layer
germinal layer with capsules
Protoscolex
•Pricyst
![Page 4: Aetiology - iacld.ir](https://reader033.vdocuments.site/reader033/viewer/2022051000/6276753fe53b5e45d469ae0b/html5/thumbnails/4.jpg)
E. granulosus
![Page 5: Aetiology - iacld.ir](https://reader033.vdocuments.site/reader033/viewer/2022051000/6276753fe53b5e45d469ae0b/html5/thumbnails/5.jpg)
E. multilocularis
![Page 6: Aetiology - iacld.ir](https://reader033.vdocuments.site/reader033/viewer/2022051000/6276753fe53b5e45d469ae0b/html5/thumbnails/6.jpg)
life cycle of Echinococcus
![Page 7: Aetiology - iacld.ir](https://reader033.vdocuments.site/reader033/viewer/2022051000/6276753fe53b5e45d469ae0b/html5/thumbnails/7.jpg)
Pathology
Slow growing & space occupying fluid filled cysts
In CE:
Liver 70%
Lungs 10-25%
Other organs <10%
In AE:
Liver 98-100%
![Page 8: Aetiology - iacld.ir](https://reader033.vdocuments.site/reader033/viewer/2022051000/6276753fe53b5e45d469ae0b/html5/thumbnails/8.jpg)
![Page 9: Aetiology - iacld.ir](https://reader033.vdocuments.site/reader033/viewer/2022051000/6276753fe53b5e45d469ae0b/html5/thumbnails/9.jpg)
Diagnosis
•Imaging techniques
•Parasitologic (Direct methods)
•Immunodiagnosis
![Page 10: Aetiology - iacld.ir](https://reader033.vdocuments.site/reader033/viewer/2022051000/6276753fe53b5e45d469ae0b/html5/thumbnails/10.jpg)
Imaging techniques
MRI
![Page 11: Aetiology - iacld.ir](https://reader033.vdocuments.site/reader033/viewer/2022051000/6276753fe53b5e45d469ae0b/html5/thumbnails/11.jpg)
Parasitologic
(PAIR)
![Page 12: Aetiology - iacld.ir](https://reader033.vdocuments.site/reader033/viewer/2022051000/6276753fe53b5e45d469ae0b/html5/thumbnails/12.jpg)
Parasitologic
H & E
PAS
Ag
Eosin test: Incubation in 0.1% eosin in PBS Take up the stain =dead Exclude the stain= alive
![Page 13: Aetiology - iacld.ir](https://reader033.vdocuments.site/reader033/viewer/2022051000/6276753fe53b5e45d469ae0b/html5/thumbnails/13.jpg)
Immunodiagnosis
o
o
o
o
CAgs
![Page 14: Aetiology - iacld.ir](https://reader033.vdocuments.site/reader033/viewer/2022051000/6276753fe53b5e45d469ae0b/html5/thumbnails/14.jpg)
Immunodiagnosis
o
o
o
o
![Page 15: Aetiology - iacld.ir](https://reader033.vdocuments.site/reader033/viewer/2022051000/6276753fe53b5e45d469ae0b/html5/thumbnails/15.jpg)
insensitive tests:
Casoni, CFT, LAT, IHA, IEP
replaced by new tests
IFA, ELISA, Immunobloting
![Page 16: Aetiology - iacld.ir](https://reader033.vdocuments.site/reader033/viewer/2022051000/6276753fe53b5e45d469ae0b/html5/thumbnails/16.jpg)
Sensitivity = (TP/TP+FN) X 100
Specificity = (TN/TN+FP) X 100
Quality & Purity of Ag
CHFAg
AgB, Ag5
![Page 17: Aetiology - iacld.ir](https://reader033.vdocuments.site/reader033/viewer/2022051000/6276753fe53b5e45d469ae0b/html5/thumbnails/17.jpg)
IFA (indirect fluorescent antibody)
![Page 18: Aetiology - iacld.ir](https://reader033.vdocuments.site/reader033/viewer/2022051000/6276753fe53b5e45d469ae0b/html5/thumbnails/18.jpg)
Ag+Ab
IFAELISA
.1
•AbAg5(arc5)
.2(DD5)
.3
![Page 19: Aetiology - iacld.ir](https://reader033.vdocuments.site/reader033/viewer/2022051000/6276753fe53b5e45d469ae0b/html5/thumbnails/19.jpg)
ELISA
Test sera in duplicate or triplicate
Control wells
blank, no sera, no Ag
Positive sera, Negative sera
Standard cut-off point:
SD of the negative controls3 mean O.D +
![Page 20: Aetiology - iacld.ir](https://reader033.vdocuments.site/reader033/viewer/2022051000/6276753fe53b5e45d469ae0b/html5/thumbnails/20.jpg)
Sensitivity
%
Specificity
%
CHFAg 80-90 75-90
AgB 90 98
ELISA
![Page 21: Aetiology - iacld.ir](https://reader033.vdocuments.site/reader033/viewer/2022051000/6276753fe53b5e45d469ae0b/html5/thumbnails/21.jpg)
AgB:
o polymeric lipoprotein, 120 KD
o thermo-stable
o highly immunogenic
o under reducing SDS-PAGE
Ag5:
lipoprotein, 400 KD
thermo-labile
![Page 22: Aetiology - iacld.ir](https://reader033.vdocuments.site/reader033/viewer/2022051000/6276753fe53b5e45d469ae0b/html5/thumbnails/22.jpg)
Immunoblotting
Molecular
weight (kD)
Sensitivity
%
Specificity
%
8/16/24/38 91 93
8/16/24 95 90
8/16 81 100
8 78 100
![Page 23: Aetiology - iacld.ir](https://reader033.vdocuments.site/reader033/viewer/2022051000/6276753fe53b5e45d469ae0b/html5/thumbnails/23.jpg)
.1ELISA
.2
DD5 or immunoblotting
![Page 24: Aetiology - iacld.ir](https://reader033.vdocuments.site/reader033/viewer/2022051000/6276753fe53b5e45d469ae0b/html5/thumbnails/24.jpg)
Treatment
Surgery
PAIR
Chemothrapy
- Albendazole
- Mebendazole